Aryl hydrocarbon receptor interacting protein targets IRF7 to suppress antiviral signaling and the induction of type I interferon

Journal of Biological Chemistry

Volumn 290, Issue 23, 2015, Pages 14729-14739

  Zhou, Qinjie ^a   Lavorgna, Alfonso ^b   Bowman, Melissa ^b,c   Hiscott, John ^d   Harhaj, Edward W ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Vaccine and Gene Therapy Institute of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; CELL CULTURE; CHEMICAL ACTIVATION; GLYCOPROTEINS; HYDROCARBONS; PROTEINS; VIRUSES;

ARYL HYDROCARBON RECEPTOR; BINDING PARTNERS; INTERFERON REGULATORY FACTORS; MURINE EMBRYONIC FIBROBLASTS; NEGATIVE REGULATORS; NUCLEAR LOCALIZATION; TYPE I INTERFERONS; VIRUS INFECTION;

ANTIBIOTICS;

ALPHA INTERFERON; AROMATIC HYDROCARBON RECEPTOR; BETA INTERFERON; INTERFERON REGULATORY FACTOR 7; TRANSCRIPTION FACTOR GAL4; ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; IRF7 PROTEIN, HUMAN; SIGNAL PEPTIDE; SMALL INTERFERING RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SENDAI VIRUS; SENDAI VIRUS INFECTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; VIRUS REPLICATION; ANIMAL; CELL LINE; GENETICS; HUMAN; IMMUNOLOGY; RNA INTERFERENCE; UPREGULATION; VIRUS INFECTION;

MURINAE;

ANIMALS; CELL LINE; HUMANS; INTERFERON REGULATORY FACTOR-7; INTERFERON-ALPHA; INTERFERON-BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; RNA INTERFERENCE; RNA, SMALL INTERFERING; UP-REGULATION; VIRUS DISEASES;

EID: 84930620010     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.633065     Document Type: Article

References (73)

1. Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., and Conzelmann., K. K., Schlee, M., Endres, S., and Hartmann, G. (2006) 5'-Triphosphate RNA is the ligand for RIG-I. Science 314, 994-997
2. Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., and Reis e Sousa, C. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314, 997-1001
3. Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., Yamaguchi, O., Otsu, K., Tsujimura, T., Koh, C. S., Reis e Sousa, C., Matsuura, Y., Fujita, T., and Akira, S. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105
4. Schoggins, J. W., and MacDuff., D. A., Imanaka, N, and Gainey., M. D., Shrestha, B., Eitson, J. L., Mar, K. B., Richardson, R. B., Ratushny, A. V., Litvak, V., Dabelic, R., Manicassamy, B., Aitchison, J. D., Aderem, A., Elliott, R. M., García-Sastre, A., Racaniello, V., Snijder, E. J., Yokoyama, W. M., Diamond, M. S., Virgin, H. W., and Rice, C. M. (2014) Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691-695
5. Gack, M. U., and Shin., Y. C., Joo, C. H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., and Jung, J. U. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920
6. Seth, R. B., Sun, L., Ea, C. K., and Chen, Z. J. (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-ΚB and IRF 3. Cell 122, 669-682
7. Liu, S., Chen, J., Cai, X., Wu, J., Chen, X., Wu, Y. T., Sun, L., and Chen, Z. J. (2013) MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. eLife 2, e00785
8. Hou, F., Sun, L., Zheng, H., Skaug, B., and Jiang., Q. X., and Chen, Z. J. (2011) MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448-461
9. Zhao, T., Yang, L., Sun, Q., Arguello, M., and Ballard., D. W., Hiscott, J., and Lin, R. (2007) The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways. Nat. Immunol. 8, 592-600
10. Sharma, S., and tenOever., B. R., Grandvaux, N, and Zhou., G. P., Lin, R., and Hiscott, J. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151
11. Basagoudanavar, S. H., Thapa, R.J., Nogusa, S., Wang, J., Beg, A. A., and Balachandran, S. (2011) Distinct roles for the NF-KB RelA subunit during antiviral innate immune responses. J. Virol. 85, 2599-2610
12. Hiscott, J., Pitha, P., Genin, P., Nguyen, H., Heylbroeck, C, Mamane, Y., Algarte, M., and Lin, R. (1999) Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res. 19, 1-13
13. Lu, R., Au, W. C, Yeow, W. S., Hageman, N., and Pitha, P. M. (2000) Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation. J. Biol. Chem. 275, 31805-31812
14. Honda, K., and Taniguchi, T. (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644-658
15. Honda, K., Yanai, H, Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., and Taniguchi, T. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434, 772-777
16. Arimoto, K., Takahashi, H, Hishiki, T., Konishi, H, Fujita, T., and Shimotohno, K. (2007) Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl. Acad. Sci. U.S.A. 104, 7500-7505
17. Fan, Y., Mao, R., Yu, Y., Liu, S., Shi, Z., Cheng, J., Zhang, H, An, L., Zhao, Y., Xu, X., Chen, Z., Kogiso, M., Zhang, D., Zhang, H., Zhang, P., Jung, J. U., Li, X., Xu, G., and Yang, J. (2014) USP21 negatively regulates antiviral response by acting as aRIG-I deubiquitinase. J. Exp. Med. 211, 313-328
18. You, F., Sun, H., Zhou, X., Sun, W., Liang, S., Zhai, Z., and Jiang, Z. (2009) PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat. Immunol. 10, 1300-1308
19. Nakhaei, P., Mesplede, T., Solis, M., Sun, Q., Zhao, T., Yang, L., Chuang, T. H, Ware, C. F., Lin, R., and Hiscott, J. (2009) The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog. 5, e1000650
20. Cui, J., Li, Y., Zhu, L., Liu, D., Songyang, Z., Wang, H. Y., and Wang, R. F. (2012) NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat. Immunol. 13, 387-395
21. Lin, R., Yang, L., Nakhaei, P., Sun, Q., Sharif-Askari, E., Julkunen, I., and Hiscott, J. (2006) Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J. Biol. Chem. 281, 2095-2103
22. Parvatiyar, K., Barber, G. N, and Harhaj, E. W. (2010) TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J. Biol. Chem. 285, 14999-15009
23. Gao, L., Coope, H., Grant, S., Ma, A., Ley, S. C, and Harhaj, E. W. (2011) ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling. J. Biol. Chem. 286, 36592-36602
24. Higgs, R., Ní Gabhann, J., Ben Larbi, N, Breen, E. P., Fitzgerald, K. A., and Jefferies, C. A. (2008) The E3 ubiquitin ligase Ro52 negatively regulates IFN-β production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 181, 1780-1786
25. Saitoh, T., Tun-Kyi, A., Ryo, A., Yamamoto, M., Finn, G., Fujita, T., Akira, S., Yamamoto, N, and Lu., K. P., and Yamaoka, S. (2006) Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7, 598-605
26. Wang, J., Yang, B., Hu, Y., Zheng, Y., Zhou, H, Wang, Y., Ma, Y., Mao, K., Yang, L., Lin, G., Ji, Y., Wu, X., and Sun, B. (2013) Negative regulation of Nmi on virus-triggered type IIFN production by targeting IRF7. J. Immunol. 191, 3393-3399
27. Yu, Y., and Hayward, G. S. (2010) The ubiquitin E3 ligase RAUL negatively regulates type I interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 33, 863-877
28. Hu, Y., Wang, J., Yang, B., Zheng, N., Qin, M., Ji, Y., Lin, G., Tian, L., Wu, X., Wu, L., and Sun, B. (2011) Guanylate binding protein 4 negatively regulates virus-induced type I IFN and antiviral response by targeting IFN regulatory factor 7. J. Immunol. 187, 6456-6462
29. Litvak, V., and Ratushny., A. V., Lampano, A. E., Schmitz, F., Huang, A. C, Raman, A., and Rust., A. G., Bergthaler, A., Aitchison, J. D., and Aderem, A. (2012) A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature 490, 421-425
30. Ma, Q., Whitlock, J. P., Jr. (1997) A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 272, 8878-8884
31. Kuzhandaivelu, N., and Cong., Y. S., Inouye, C, and Yang., W. M., and Seto, E. (1996) XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res. 24, 4741-4750
32. Carver, L. A., and Bradfield, C. A. (1997) Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J. Biol. Chem. 272, 11452-11456
33. Morgan, R. M., Hernández-Ramírez, L. C, Trivellin, G., Zhou, L., Roe, S. M., Korbonits, M., and Prodromou, C. (2012) Structure of the TPR domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the TPR domain of AIP is sufficient for pituitary adenoma predisposition. PLoS One 7, e53339
34. Carver, L. A., and La Pres., J. J., Jain, S., Dunham, E. E., and Bradfield, C. A. (1998) Characterization of the Ah receptor-associated protein, ARA9. J. Biol. Chem. 273, 33580-33587
35. Meyer, B. K., and Perdew, G. H. (1999) Characterization of the AhRhsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization. Biochemistry 38, 8907-8917
36. Kazlauskas, A., Poellinger, L., and Pongratz, I. (2000) The immunophilinlike protein XAP2 regulates ubiquitination and subcellular localization of the dioxin receptor. J. Biol. Chem. 275, 41317-41324
37. Petrulis, J. R., and Hord., N. G., and Perdew, G. H. (2000) Subcellular localization of the aryl hydrocarbon receptor is modulated by the immunophilin homolog hepatitis B virus X-associated protein 2. J. Biol. Chem. 275, 37448-37453
38. Petrulis, J. R., Kusnadi, A., Ramadoss, P., Hollingshead, B., and Perdew, G. H. (2003) The hsp90 Co-chaperone XAP2 alters importin β recognition of the bipartite nuclear localization signal of the Ah receptor and represses transcriptional activity. J. Biol. Chem. 278, 2677-2685
39. Kashuba, E., Kashuba, V., Pokrovskaja, K., Klein, G., and Szekely, L. (2000) Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with hepatitis B virus X antigen. Oncogene 19, 1801-1806
40. Schimmack, G., Eitelhuber, A. C, Vincendeau, M., Demski, K., Shinohara, H, Kurosaki, T., and Krappmann, D. (2014) AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-KB signaling upon T cell activation. Cell Commun. Signal. 12, 49
41. Raitila, A., and Lehtonen., H. J., Arola, J., Heliövaara, E., Ahlsten, M., Georgitsi, M., Jalanko, A., Paetau, A., and Aaltonen., L. A., and Karhu, A. (2010) Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression. Am. J. Pathol. 177, 1969-1976
42. Lin, R., Mamane, Y., and Hiscott, J. (2000) Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 275, 34320-34327
43. Ning, S., Campos, A.D., Darnay, B. G., Bentz, G.L., and Pagano, J.S. (2008) TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1. Mol. Cell. Biol. 28, 6536-6546
44. Lavorgna, A., and Harhaj, E. W. (2012) An RNA interference screen identifies the Deubiquitinase STAMBPL1 as a critical regulator of human T-cell leukemia virus type 1 tax nuclear export and NF-KB activation. J. Virol. 86, 3357-3369
45. Charoenthongtrakul, S., Gao, L., Parvatiyar, K., Lee, D., and Harhaj, E. W. (2013) RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. PLoS One 8, e53717
46. Yang, H, and Lin., C. H., Ma, G., Baffi, M. O., and Wathelet, M. G. (2003) Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators. J. Biol. Chem. 278, 15495-15504
47. Shembade, N., and Harhaj., N. S., Parvatiyar, K., Copeland, N. G., Jenkins, N.A., Matesic, L. E., and Harhaj, E. W. (2008) The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9, 254-262
48. Balachandran, S., and Barber, G. N. (2004) Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 5, 51-65
49. Li, S., Wang, L., Berman, M., Kong, Y. Y., and Dorf, M. E. (2011) Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35, 426-440
50. Lin, B. C, Sullivan, R., Lee, Y., Moran, S., Glover, E., and Bradfield, C. A. (2007) Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality. J. Biol. Chem. 282, 35924-35932
51. Fitzgerald, K. A., and McWhirter., S. M., Faia, K. L., Rowe, D. C, Latz, E., and Golenbock., D. T., Coyle, A. J., Liao, S. M., and Maniatis, T. (2003) IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 4, 491-496
52. Lin, R., Heylbroeck, C, and Pitha., P. M., and Hiscott, J. (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18, 2986-2996
53. Marié, I., Smith, E., Prakash, A., and Levy, D. E. (2000) Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain. Mol. Cell. Biol. 20, 8803-8814
54. González-Navajas, J. M., Lee, J., David, M., and Raz, E. (2012) Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12, 125-135
55. Bonjardim, C. A., and Ferreira., P. C., and Kroon, E. G. (2009) Interferons: signaling, antiviral and viral evasion. Immunol. Lett. 122, 1-11
56. Stetson, D.B., and Medzhitov, R. (2006) Type I interferons in host defense. Immunity 25, 373-381
57. Borden, E. C., and Sen., G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G.R., and Stark, G.R. (2007) Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6, 975-990
58. Sathish, N, and Zhu., F. X., Golub, E. E., Liang, Q., and Yuan, Y. (2011) Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45. J. Biol. Chem. 286, 746-756
59. Chang, T. H., Kubota, T., Matsuoka, M., Jones, S., and Bradfute., S. B., Bray, M., and Ozato, K. (2009) Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog. 5, e1000493
60. Hahn, A. M., and Huye., L. E., Ning, S., Webster-Cyriaque, J., and Pagano, J. S. (2005) Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J. Virol. 79, 10040-10052
61. Wu, L., Fossum, E., Joo, C. H., Inn, K. S., Shin, Y. C., Johannsen, E., Hutt-Fletcher, L. M., Hass, J., and Jung, J. U. (2009) Epstein-Barr virus LF2: an antagonist to type I interferon. J. Virol. 83, 1140-1146
62. Yu, Y., and Wang., S. E., and Hayward, G.S. (2005) The KSHVimmediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22, 59-70
63. Zhu, F. X., and King., S. M., Smith, E. J., Levy, D. E., and Yuan, Y. (2002) A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl. Acad. Sci. U.S.A. 99, 5573-5578
64. Joo, C. H, Shin, Y. C., Gack, M., Wu, L., Levy, D., and Jung, J. U. (2007) Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. J. Virol. 81, 8282-8292
65. Charoenthongtrakul, S., Zhou, Q., Shembade, N, and Harhaj., N. S., and Harhaj, E. W. (2011) Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-κB-dependent induction of SOCS1. J. Virol. 85, 6955-6962
66. Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N, Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., and Fujii-Kuriyama, Y. (1997) Loss of teratogenic response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2, 645-654
67. Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., and Renauld., J. C., and Stockinger, B. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109
68. Quintana, F. J., and Basso., A. S., Iglesias, A. H, Korn, T., and Farez., M. F., Bettelli, E., Caccamo, M., Oukka, M., and Weiner, H. L. (2008) Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71
69. Burleson, G. R., Lebrec, H, and Yang., Y. G., Ibanes, J. D., Pennington, K. N, and Birnbaum, L. S. (1996) Effect of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam. Appl. Toxicol. 29, 40-47
70. Lawrence, B. P., and Roberts., A. D., Neumiller, J. J., Cundiff, J. A., and Woodland, D. L. (2006) Aryl hydrocarbon receptor activation impairs the priming but not the recall of influenza virus-specific CD8+ T cells in the lung. J. Immunol. 177, 5819-5828
71. Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., and Ebeling., T. M., Salmela, P. I., Paschke, R., Gündogdu, S., De Menis, E., Mäkinen, M. J., Launonen, V., Karhu, A., and Aaltonen, L. A. (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312, 1228-1230
72. Chahal, H. S., and Chapple., J. P., Frohman, L. A., Grossman, A. B., and Korbonits, M. (2010) Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol. Metab. 21, 419-427
73. Igreja, S., and Chahal., H. S., King, P., Bolger, G. B., Srirangalingam, U., Guasti, L., and Chapple., J. P., Trivellin, G., Gueorguiev, M., Guegan, K., Stals, K., Khoo, B., Kumar, A. V, Ellard, S., and Grossman., A. B., and Korbonits, M. (2010) Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum. Mutat. 31, 950-960